Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Elsevier Science full text link Elsevier Science Free PMC article
Full text links

Actions

Share

.2013 Oct;11(10):1270-1275.e1.
doi: 10.1016/j.cgh.2013.04.020. Epub 2013 Apr 30.

Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome

Affiliations

Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome

Andrea Shin et al. Clin Gastroenterol Hepatol.2013 Oct.

Abstract

Background & aims: There is an unclear relationship among bowel symptoms, excretion of unconjugated fecal bile acid (UBA), and colonic transit in irritable bowel syndrome (IBS). We measured total and main individual UBA in fecal samples of patients with IBS and assessed relationships among stool frequency or consistency, fecal UBA (total and individual), and colonic transit.

Methods: In this study 30 healthy volunteers (controls), 31 subjects with IBS with diarrhea (IBS-D), and 30 with IBS with constipation (IBS-C) were placed on 4-day diets containing 100 g fat; we measured stool characteristics, total fecal UBA and fat levels, and overall colonic transit. We assessed univariate associations of total and individual levels of fecal UBA with phenotype (controls, IBS-D, IBS-C) by using the Kruskal-Wallis test; associations between end points were assessed by using Spearman correlations. With response surface regression models, we assessed relationships between stool, colonic transit, and fecal total and secretory UBA.

Results: There was a significant association between total fecal UBA and phenotype (P = .029); the association was greater for IBS-D than IBS-C, compared with controls. Fecal levels of primary UBAs (cholic and chenodeoxycholic acids) were higher in subjects with IBS-D, compared with controls (both P < .01). Levels of fecal secretory UBAs (chenodeoxycholic acid, P = .019; deoxycholic acid, P = .025) were lower in subjects with IBS-C compared with controls, whereas levels of the nonsecretory UBA, lithocholic acid, were higher (P = .020). There were significant univariate associations between stool number and form and total fecal UBA (including percentages of lithocholic acid, chenodeoxycholic acid and cholic acid), fecal fat, and colonic transit at 24 and 48 hours after eating. In the regression models, the relative contribution of colonic transit was consistently greater and largely independent of the contribution of bile acids.

Conclusions: Measurements of individual UBAs identify changes associated with stool characteristics in patients with IBS; these effects are independent of the effects of colonic transit.

Keywords: Abdominal Pain; BA; C; CA; CDCA; CT; Constipation; D; DCA; Diarrhea; FGID; GC; HAD; HV; Hospital Anxiety and Depression Scale; IBS; LCA; Secretory; UBA; UDCA; bile acid; chenodeoxycholic acid; cholic acid; colonic transit; constipation; deoxycholic acid; diarrhea; functional gastrointestinal disorder; geometric center; healthy volunteers; irritable bowel syndrome; lithocholic acid; unconjugated bile acid; ursodeoxycholic acid.

Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Mayo Clinic, Dr. M. Camilleri and Mr. D. Burton have filed a provisional patent on treatment of constipation with delayed release preparation of bile acid. The other authors have no conflicts of interest.

Figures

Figure 1
Figure 1
Comparison of total 48-hour stool unconjugated bile acids (UBA) in the three phenotype subgroups [constipation-predominant irritable bowel syndrome (IBS-C), diarrhea-predominant irritable bowel syndrome (IBS-D), and healthy volunteers (HV)]. Data show median, interquartile range and 5–95th percentile range, as well as outliers. There was a significant three-group (overall) association between total fecal UBA and phenotype group, but no significant differences between IBS-D or IBS-C and controls. Red data points denote patients with prior cholecystectomy.
Figure 2
Figure 2
Surface plots of relationship of stool number or form with total and secretory fecal unconjugated bile acids (BA) and colonic transit (CT) at 24 hours (GC24). Note that stool number and form increase with increased CT measurement (x axis) and with increased fecal unconjugated total or secretory BA (z axis) at low CT measurements. However, the surface plot shows that both stool number and form were lower when the CT was fastest and fecal BA highest.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Camilleri M. Peripheral Mechanisms in Irritable Bowel Syndrome. N Engl J Med. 2012;367:1626–1635. - PubMed
    1. Camilleri M, McKinzie S, Busciglio I, et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008;6:772–781. - PMC - PubMed
    1. Wedlake L, A'Hern R, Russell D, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009;30:707–717. - PubMed
    1. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol. 2010;8:159–165. - PMC - PubMed
    1. Abrahamsson H, Ostlund-Lindqvist AM, Nilsson R, et al. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand J Gastroenterol. 2008;43:1483–1488. - PubMed

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Elsevier Science full text link Elsevier Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp